|
| Baseline | At 6th week | P Value | At 12th week | P Value |
| Hemoglobin (g/dl) |
|
|
|
|
|
| Group A (n = 20) | 9.47 ± 1.99 | 10.34 ± 1.80 | 0.179 | 11.00 ± 1.58 | 0.009* |
| Group B (n = 20) | 9.79 ± 1.54 | 10.57 ± 1.47 | 0.004* | 11.13 ± 0.73 | 0.001* |
| ESR (mm in 1st hr) |
|
|
|
|
|
| Group A (n = 20) | 86.50 ± 26.71 | 54.55 ± 34.00 | 0.003* | 34.80 ± 24.38 | <0.001* |
| Group B (n = 20) | 71.35 ± 35.07 | 37.85 ± 28.37 | <0.001* | 27.80 ± 15.36 | <0.001* |
| Total WBC count (×10⁹/L) |
|
|
|
|
|
| Group A (n = 20) | 14.23 ± 4.05 | 12.36 ± 5.63 | 0.094 | 12.35 ± 7.46 | 0.162 |
| Group B (n = 20) | 11.61 ± 3.90 | 10.33 ± 2.71 | 0.096 | 16.72 ± 2.56 | 0.388 |
| Neutrophil (%) |
|
|
|
|
|
| Group A (n = 20) | 69.00 ± 11.00 | 60.05 ± 16.79 | 0.006* | 60.70 ± 20.42 | 0.046* |
| Group B (n = 20) | 63.00 ± 13.39 | 60.95 ± 13.60 | 0.605 | 54.65 ± 11.82 | 0.21 |
| Lymphocytes (%) |
|
|
|
|
|
| Group A (n = 20) | 22.85 ± 7.22 | 32.70 ± 14.39 | 0.003* | 32.10 ± 17.29 | 0.014* |
| Group B (n = 20) | 30.65 ± 11.86 | 31.40 ± 7.63 | 0.820 | 34.50 ± 10.58 | 0.252 |
| Platelet count (×10⁹/L) |
|
|
|
|
|
| Group A (n = 20) | 472.45 ± 135.05 | 605.75 ± 738.83 | 0.415 | 436.30 ± 128.05 | 0.380 |
| Group B (n = 20) | 534.40 ± 194.74 | 509.00 ± 150.12 | 0.635 | 455.72 ± 167.77 | 0.141 |
| Serum ALT (U/L) |
|
|
|
|
|
| Group A (n = 20) | 28.95 ± 31.21 | 50.60 ± 131.77 | 0.487 | 15.45 ± 7.90 | 0.072 |
| Group B (n = 20) | 22.55 ± 15.51 | 16.35 ± 5.58 | 0.063 | 13.45 ± 5.53 | 0.028* |